{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Washington",
      "advisory_committee_description": "Clinical Toxicology",
      "address_1": "1875 Eye St. NW Suite 625",
      "address_2": "",
      "statement_or_summary": "",
      "product_code": "DPO",
      "openfda": {
        "device_name": "Radioimmunoassay, Digoxin (125-I), Rabbit Antibody, Coated Tube Sep.",
        "medical_specialty_description": "Clinical Toxicology",
        "regulation_number": "862.3320",
        "device_class": "2"
      },
      "zip_code": "20006",
      "applicant": "Bd Becton Dickinson Vacutainer Systems Preanalytic",
      "decision_date": "1977-10-07",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "IGOXIN SOLID PHASE RIA",
      "advisory_committee": "TX",
      "contact": "",
      "expedited_review_flag": "",
      "k_number": "K771638",
      "state": "DC",
      "date_received": "1977-08-26",
      "review_advisory_committee": "TX",
      "postal_code": "20006",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}